Varex Imaging Corp

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $640.89M
  • PE -13
  • Debt $492.90M
  • Cash $170.40M
  • EV $963.39M
  • FCF $20.40M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$47.70M
EBIT$32.10M
ROE-9%
ROA3%
FCF$20.40M
Equity$549.20M
Growth Stability-184%
PE-13.44
PEG-0.33
PB1.17
P/FCF31.42
P/S0.79
Price/Cash0.27
Debt/Equity0.9
Debt/FCF24.16
Net Margins-6%
Gross Margins32%
Op. Margins4%
Earnings CAGR-2%
Sales Growth YoY-10%
Sales Growth QoQ-2%
Sales CAGR4%
FCF CAGR-2%
Equity CAGR4%
Earnings Stability-0.03
Earnings Growth YoY-257%
Earnings Growth QoQ-4K%
Earnings CAGR 5Y41%
Sales CAGR 5Y3%
FCF CAGR 5Y5%
Equity CAGR 5Y6%
Earnings CAGR 3Y-0%
Sales CAGR 3Y-0%
FCF CAGR 3Y-9%
Equity CAGR 3Y5%
Market Cap$640.89M
Revenue$811.00M
Assets$1.22B
Total Debt$492.90M
Cash$170.40M
Shares Outstanding40.77M
EV963.39M
Earnings Score6%
Moat Score14%
Safety Score41%
Final Score20%
Working Capital454M
Current Ratio3.32
Gross Profit$256.90M
Shares Growth 3y1%
Equity Growth QoQ-8%
Equity Growth YoY-5%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.

SEC Filings

Direct access to Varex Imaging Corp (VREX) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Sep 27
    • 10-Q Jun 28
    • 10-Q Mar 29
  • 2023
    • 10-Q Dec 29
    • 10-K Sep 29
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-Q Dec 30
    • 10-K Sep 30
    • 10-Q Jul 01
    • 10-Q Apr 01

Sector Comparison

How does Varex Imaging Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Varex Imaging Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -2%
Stability -3%
loading chart...

Varex Imaging Corp Discounted Cash Flow

Fully customizable DCF calculator online for Varex Imaging Corp.

= $175M
012345678910TV
fcf$20M$20M$19M$19M$19M$18M$18M$17M$17M$17M$16M$161M
DCF$18M$16M$14M$13M$11M$10M$8.9M$7.9M$7M$6.2M$62M
Value$175M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years10/201509/201609/201709/201809/201910/202009/202109/202209/202309/2024TTM
Net Margins13%11%7%4%2%-8%2%4%5%-6%-6%
ROA-18%8%5%4%-3%6%7%6%3%3%
ROE-13%14%6%3%-12%4%6%8%-9%-9%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years10/201509/201609/201709/201809/201910/202009/202109/202209/202309/2024TTM
Debt over FCF-08.96.528.28-49.886.24-102.685.1324.1624.16
Debt over Equity-01.280.990.961.10.970.830.770.90.9
Growth Stability---41%32%-184%----149%-184%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years10/201509/201609/201709/201809/201910/202009/202109/202209/202309/2024CAGR 5Y
Revenue YoY growth--2%13%11%1%-5%11%5%4%-9%3%
Earnings YoY growth--14%-25%-47%-44%-474%-130%74%59%-199%41%
Equity YoY growth-6%-28%13%5%4%7%10%6%-5%6%
FCF YoY growth--11%20%19%-20%-120%-852%-106%-2K%-77%5%